1-3 of 3
Christina Nickenig, MD
Close
Sort by
Journal Articles

Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Joerg Schubert, Marita Ziepert, Eva Lengfelder, PD, Martin Mohren, PD, Norma Peter, MD, Marcel Reiser, PD, Michael Clemens, Christina Nickenig, MD, Maike deWit, PD, Anthony Ho, Hartmut Eimermacher, MD, Lorenz Truemper, Martin Hoffmann, MD, Roland Mertelsmann, Bernd Metzner, MD, Hans-Guenther Mergenthaler, Ruediger Liersch, MD, Ulrich Duehrsen, Leopold Balleisen, Frank Hartmann, Viola Poeschel, Norbert Schmitz, Markus Loeffler, Michael Pfreundschuh
Journal: Blood
Blood (2007) 110 (11): 788.
https://doi.org/10.1182/blood.V110.11.788.788
Published: 2007
Journal Articles

Serum Levels and Pharmacokinetic of Rituximab in Bi-Weekly R-CHOP in Elderly Patients with DLBCL Treated in the RICOVER-60 Trial.

Marcel Reiser, MD, Michael K. Wenger, MD, Christina Nickenig, MD, N. Peter, MD, Christian Kuhn, MD, Bernd Metzner, MD, Martin Theisohn, MD, Michael Pfreundschuh, MD
Journal: Blood
Blood (2006) 108 (11): 2748.
https://doi.org/10.1182/blood.V108.11.2748.2748
Published: 2006
Journal Articles

CHOP Improves Response Rates but Not Overall Survival in Follicular and Mantle Cell Lymphoma (MCL)- Results of a Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG ).

Christina Nickenig, MD, Martin H. Dreyling, MD, PhD, Eva Schiegnitz, MSc, Michael Pfreundschuh, MD, PhD, Lorenz H. Truemper, MD, PhD, Marcel Reiser, MD, Hannes Wandt, MD, PhD, Eva Lengfelder, MD, PhD, Wolf-Dieter Ludwig, MD, PhD, Wolfgang E. Berdel, MD, PhD, Bernd Metzner, MD, Georg Hess, MD, Roswitha Forstpointner, MD, Reza Parwaresch, MD, PhD, Joerg Hasford, MD, PhD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 611.
https://doi.org/10.1182/blood.V104.11.611.611
Published: 2004